targeting the mechanisms of treatment resistance in cancer with Nicholas  Goldner | 222

0 Views· 09/26/23
cancer – Learning with Lowell
0

Nicholas Goldner, PhD, is the CEO and co-founder of resistanceBio, where he leads a mission to outsmart cancer by developing innovative therapies targeting treatment resistance mechanisms. He also serves as a venture partner at Pioneer... Source

Show more

 0 Comments sort   Sort By


Up next